SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Nanoparticles Assemble By Millions To Encase Oil Drops, Rice University Study
May 30, 2008
 · 
1 min read
Lone Star Bio
National Instruments Corporation Advances Medical Device Design with Technology and Training
May 30, 2008
 · 
1 min read
Drug Development
Fireflies’ Glow Helps UT Southwestern Medical Center Researchers Track Cancer Drug’s Effectiveness
May 29, 2008
 · 
1 min read
Lone Star Bio
CT May Better Predict Those At Higher Risk For Heart Disease, University of Texas Southwestern Medical Center Study
May 28, 2008
 · 
1 min read
Biotech Bay
Taking the Gloves Off
May 27, 2008
 · 
2 min read
Lone Star Bio
Oocyte-Specific Gene Mutations Cause Premature Ovarian Failure, Baylor College of Medicine And Shandong University Study Finds
May 23, 2008
 · 
1 min read
Lone Star Bio
Monitors Urged By American Heart Association For All With High Blood Pressure
May 23, 2008
 · 
1 min read
Drug Development
Two Drugs For Heart Failure Show Mixed Results; Novartis Pharmaceuticals Corporation’s Diovan Should Be Used More Often And Scios Inc.'s Natrecor Should Not Be Used At All, VA Medical Center And Baylor University Research Shows
May 22, 2008
 · 
1 min read
Lone Star Bio
Blood-clotting Protein Modified For People With Hard-to-treat Hemophilia, University of Texas Health Science Center Study
May 22, 2008
 · 
1 min read
Lone Star Bio
Genes For Musical Aptitude In Finnish Families Located, University of Helsinki and Southwest Foundation For Biomedical Research Study
May 20, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More